IKM — 1nkemia IUCT SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for 1nkemia IUCT SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2017 December 31st	2018 December 31st	R2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4.7	5.46	1.74	0.146	0.148
Cost of Revenue
Gross Profit	4.31	4.99	2.93	0.076	0.136
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5.46	20.2	-2.16	2.53	-0.572
Operating Profit	-0.761	-14.8	3.89	-2.39	0.72
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.936	-15.6	3.59	-2.65	-0.119
Provision for Income Taxes
Net Income After Taxes	-0.664	-24.4	3.54	-2.65	-0.119
Minority Interest
Net Income Before Extraordinary Items
Net Income	-0.681	-24.3	3.7	-2.65	-0.113
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.681	-24.3	3.7	-2.65	-0.113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.032	-0.482	0.012	-0.022	-0.038
Dividends per Share